What is Viking Therapeutics, Inc's Market Cap?

Viking Therapeutics, Inc's Market Cap is $3.8B, based on as-reported figures from SEC (XBRL) filings.

What is Viking Therapeutics, Inc's Enterprise Value?

Viking Therapeutics, Inc's Enterprise Value is $3.6B, based on as-reported figures from SEC (XBRL) filings.

What is Viking Therapeutics, Inc's Revenue (TTM)?

Viking Therapeutics, Inc's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Viking Therapeutics, Inc's Net Income (TTM)?

Viking Therapeutics, Inc's Net Income (TTM) is -$534.8M, based on as-reported figures from SEC (XBRL) filings.

What is Viking Therapeutics, Inc's Diluted EPS (TTM)?

Viking Therapeutics, Inc's Diluted EPS (TTM) is -4.58, based on as-reported figures from SEC (XBRL) filings.

What is Viking Therapeutics, Inc's Net Debt?

Viking Therapeutics, Inc's Net Debt is -$125.8M, based on as-reported figures from SEC (XBRL) filings.

Viking Therapeutics, Inc (VKTX) Financial Statements

Viking Therapeutics, Inc

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG006LGV887

XNAS · usd

32.36▼ 0.34 (-1.05%)

As of 2026-09-10

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close32.70

Day's Range32.59 – 34.60

52-Week Range22.96 – 43.15

Volume2.0M

Avg Volume1.8M

Share Statistics

Shares Outstanding

Employees53

ExchangeXNAS

Listed2015-04-29

Share count as of July 15, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Viking Therapeutics, Inc (VKTX)

What is Viking Therapeutics, Inc's Market Cap?: Viking Therapeutics, Inc's Market Cap is $3.8B, based on as-reported figures from SEC (XBRL) filings.
What is Viking Therapeutics, Inc's Enterprise Value?: Viking Therapeutics, Inc's Enterprise Value is $3.6B, based on as-reported figures from SEC (XBRL) filings.
What is Viking Therapeutics, Inc's Revenue (TTM)?: Viking Therapeutics, Inc's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Viking Therapeutics, Inc's Net Income (TTM)?: Viking Therapeutics, Inc's Net Income (TTM) is -$534.8M, based on as-reported figures from SEC (XBRL) filings.
What is Viking Therapeutics, Inc's Diluted EPS (TTM)?: Viking Therapeutics, Inc's Diluted EPS (TTM) is -4.58, based on as-reported figures from SEC (XBRL) filings.
What is Viking Therapeutics, Inc's Net Debt?: Viking Therapeutics, Inc's Net Debt is -$125.8M, based on as-reported figures from SEC (XBRL) filings.